ArticleFrontiers in oncology2021

Which Clinicopathologic Parameters Suggest Primary Resistance to Palbociclib in Combination With Letrozole as the First-Line Treatment for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer?

Ji-Yeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.